|
|
For your IND guide and full access to our accelerated reporting timelines, including a full-size Gantt chart, please log in to The Source℠. If you are not a member of The Source℠, our new online scientific and educational information center, please click here to register.
For more information about our preclinical capabilities, contact us at 1.877.CRIVER.1 (1.877.274.8371) or askcharlesriver@crl.com.
|
Investigative New Drug, IND, IND Guide, Investigative New Drug Guide, filing of an Investigative New Drug, IND submission, toxicology, IND program, IND proposal, IND Quote, GLP Toxicology lead-in timelines, Date for IND-submission, Gantt chart, IND Gantt, Gantt timelines, IND toxicology, PRELIMINARY TOXICOLOGY, standard preclinical packages, single dose toxicity, repeat dose range-finding study, REPEAT DOSE TOXICOLOGY, Species Selection, IND-enabling preclinical programs, IND-enabling, Study Duration and Dose, SAFETY PHARMACOLOGY, GENETIC TOXICITY, Safety pharm, safety assessment, gene-tox, genetic toxicology
IND Toxicology Research Guide | Charles River Preclinical Services
Learn through our years of experience, unique range of services and best-in-class expertise how Charles River is best suited to help you successfully initiate and complete your IND-enabling program.